The pharmaceutical industry is making use of AI for discovering new-fangled drugs. January 2020 witnessed the invention of the very first drug molecule using AI, whose patent lay with Japanese and British scientists. The medicine is being used for treating OCD (obsessive-compulsive disorder). Likewise, several promising formulas are being discovered as an outcome of AI-enabled lab experimenting. This would how the Biosensors market look in the near future.
According to a new market report published by Persistence Market Research “Global Market Study on Biosensor: Asia-Pacific to Witness Highest Growth by 2020,” the global biosensor market was valued at USD 12,963.6 million in 2014 and is expected to grow at a CAGR of 9.7% from 2014 to 2020, to reach an estimated value of USD 22,551.2 million in 2020.
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/3589
Globally, the biosensors market is witnessing significant growth due to increasing demand of point of care testing. In addition, rising prevalence of chronic and lifestyle associated diseases, growing geriatric population, increasing application of biosensors in various industries and growing application of nanotechnology in healthcare are also driving the growth of the market.
In addition, emergence and demand of personalized medicine and non-invasive biosensors would also drive the growth for the market. However, strict regulatory requirements and reimbursement policy issues in healthcare system hamper growth of the global biosensors market. In addition, the regulatory process is not keeping pace with the rapid development of new medical technologies.
Some of the major players in the biosensors market:
- Abbott Laboratories, Inc.
- Siemens Healthcare.
- Nova Biomedical Corporation.
- Bayer AG.
- Johnson and Johnson.
- Medtronic, Inc.
- Hoffmann-La Roche, Ltd.
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/3589
In North America, growing aging population, increasing health awareness, rising chronic and lifestyle diseases, technological developments for various home use applications, and appropriate insurance coverage are driving the use of biosensor devices in the market.
In Europe, the biosensors device market is driven by rising diagnostic requirements due to increasing lifestyle associated diseases, aging population and improving healthcare infrastructure. On the other hand, increasing healthcare costs has shifted the focus of healthcare from hospitals to home, which would increase the use of biosensors devices in the region.
However, Asia is becoming one of the most attractive markets for medical device companies. The growth for biosensor devices in Asia is much higher than developed countries due to widening health insurance penetration, large population base and up-gradation of health care systems.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/3589
The biosensors market is segmented as follows:
Biosensors market, by technology
- Electrochemical biosensors
- Optical biosensors
- Piezoelectric biosensors
- Thermistor biosensors
Biosensors market, by application
- Medical diagnostics
- Food toxicity detection
- Industrial process control
- Agricultural testing
Biosensors market, by end user
- Point-of-care testing
- Home healthcare diagnostics
- Research laboratories
- Security and bio-defense
Biosensors market, by geography
- North America
- Rest of the World (RoW)
About us: Persistence Market Research
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353